363 related articles for article (PubMed ID: 28666762)
1. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
3. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
[TBL] [Abstract][Full Text] [Related]
4. Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Narducci F; Grande R; Mentuccia L; Trapasso T; Sperduti I; Magnolfi E; Fariello AM; Gemma D; Gamucci T
Support Care Cancer; 2012 Jun; 20(6):1221-6. PubMed ID: 21688165
[TBL] [Abstract][Full Text] [Related]
5. Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
Dai WF; Beca J; Guo H; Isaranawatchai W; Schwartz D; Naipaul R; Arias J; Qiao Y; Gavura S; Redmond-Misner R; Ismail Z; Barbera L; Chan K
Cancer Med; 2020 Jan; 9(1):215-224. PubMed ID: 31736256
[TBL] [Abstract][Full Text] [Related]
6. The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.
Tassinari D; Montanari L; Maltoni M; Ballardini M; Piancastelli A; Musi M; Porzio G; Minotti V; Caraceni A; Poggi B; Stella A; Aielli F; Scarpi E
Support Care Cancer; 2008 Apr; 16(4):359-70. PubMed ID: 17629751
[TBL] [Abstract][Full Text] [Related]
7. Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale.
O'Mahony S; Nathan S; Mohajer R; Bonomi P; Batus M; Fidler MJ; Wells K; Kern N; Sims S; Amin D
Am J Hosp Palliat Care; 2016 May; 33(4):374-80. PubMed ID: 25670717
[TBL] [Abstract][Full Text] [Related]
8. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients.
Yennurajalingam S; Kim YJ; Zhang Y; Park J; Arthur J; Chisholm GB; Williams JL; Bruera E
Palliat Support Care; 2018 Feb; 16(1):23-31. PubMed ID: 28264748
[TBL] [Abstract][Full Text] [Related]
10. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
11. Symptom Assessment for Patients with Non-small Cell Lung Cancer Scheduled for Chemotherapy.
Silvoniemi M; Vasankari T; Löyttyniemi E; Valtonen M; Salminen E
Anticancer Res; 2016 Aug; 36(8):4123-8. PubMed ID: 27466520
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy.
Ma K; Xu W; Wang C; Li B; Su K; Li W
Cancer Biomark; 2017; 18(3):297-303. PubMed ID: 27983538
[TBL] [Abstract][Full Text] [Related]
13. Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma.
Graham J; Gingerich J; Lambert P; Alamri A; Czaykowski P
Curr Oncol; 2018 Aug; 25(4):e319-e323. PubMed ID: 30111978
[TBL] [Abstract][Full Text] [Related]
14. A new scoring system for predicting survival in patients with non-small cell lung cancer.
Schild SE; Tan AD; Wampfler JA; Ross HJ; Yang P; Sloan JA
Cancer Med; 2015 Sep; 4(9):1334-43. PubMed ID: 26108458
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
Nieder C; Kämpe TA
Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
[TBL] [Abstract][Full Text] [Related]
16. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer.
Zeng L; Zhang L; Culleton S; Jon F; Holden L; Kwong J; Khan L; Tsao M; Danjoux C; Sahgal A; Barnes E; Chow E
J Palliat Med; 2011 Mar; 14(3):337-42. PubMed ID: 21254813
[TBL] [Abstract][Full Text] [Related]
17. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.
Wang XS; Shi Q; Lu C; Basch EM; Johnson VE; Mendoza TR; Mobley GM; Cleeland CS
Cancer; 2010 Jan; 116(1):137-45. PubMed ID: 19852033
[TBL] [Abstract][Full Text] [Related]
19. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
[TBL] [Abstract][Full Text] [Related]
20. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
